Leila Dorling

Leila Dorling

UNVERIFIED PROFILE

Are you Leila Dorling?   Register this Author

Register author
Leila Dorling

Leila Dorling

Publications by authors named "Leila Dorling"

Are you Leila Dorling?   Register this Author

16Publications

504Reads

23Profile Views

Hereditary breast and ovarian cancer: successful systematic implementation of a group approach to genetic counselling.

Fam Cancer 2017 01;16(1):51-56

Consultation d'Oncogénétique, Département de Médecine Oncologique, Gustave Roussy Cancer Campus Grand Paris, 114 rue Edouard Vaillant, 94805, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-016-9929-xDOI Listing
January 2017

Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity.

Clin Cancer Res 2016 Mar 28;22(6):1413-20. Epub 2015 Oct 28.

Institute of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital NHS Foundation Trust, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751620PMC
March 2016

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.

Nat Genet 2014 Aug 29;46(8):891-4. Epub 2014 Jun 29.

1] Fundación Pública Galega de Medicina Xenómica, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain. [2] Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3020DOI Listing
August 2014

Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel.

Clin Cancer Res 2014 May 5;20(9):2466-75. Epub 2014 Mar 5.

Authors' Affiliations: Department of Oncology and Strangeways Research Laboratory, University of Cambridge; Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way; Cambridge Experimental Cancer Medicine Centre, Cambridge; Warwick Clinical Trials Unit, University of Warwick; and Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-3232DOI Listing
May 2014

Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis.

J Clin Oncol 2013 Dec 16;31(36):4488-95. Epub 2013 Sep 16.

Mukesh B. Mukesh, Gillian C. Barnett, Jennifer S. Wilkinson, Anne M. Moody, Charles Wilson, Wendi Qian, Nicola Twyman, Neil G. Burnet, and Charlotte E. Coles, Cambridge University Hospitals National Health Service Foundation Trust; Gillian C. Barnett, Charleen Chan Wah Hak, and Neil G. Burnet, University of Cambridge; and Gordon C. Wishart, Anglia Ruskin University, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.7842DOI Listing
December 2013